LOAMU
AMRI

Lombard Odier Asset Management (USA)’s Albany Molecular Research Inc AMRI Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-421,100
Closed -$7.64M – 305
2017
Q1 		$5.91M Buy
+421,100
New +$6.9M 0.56% 56

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s AMRI Position: Q2 2017 in Review

Lombard Odier Asset Management (USA) sold out of Albany Molecular Research Inc (AMRI) in Q2 2017, closing a stake of 421,100 shares — an estimated $7.64M sold.

Lombard Odier Asset Management (USA) first reported a position in AMRI in Q1 2017 and held it in 1 quarter. The position peaked at $5.91M in Q1 2017. 136 funds tracked by Wall St. Rank hold AMRI as of Q2 2017.

  • Lombard Odier Asset Management (USA) reported no remaining Albany Molecular Research Inc position as of Q2 2017 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 421,100 Albany Molecular Research Inc shares in Q2 2017, an estimated $7.64M.
  • Lombard Odier Asset Management (USA) first reported a position in Albany Molecular Research Inc in Q1 2017 and held it in 1 quarter.
  • Lombard Odier Asset Management (USA)'s Albany Molecular Research Inc position peaked at $5.91M in Q1 2017.
  • 136 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2017.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q2 2017, filed 14 Aug 2017.